INNOVIVE Pharmaceuticals Reports Q3 Results
16th Nov 2006, 08:53 GMT
INNOVIVE Pharmaceuticals, a biopharmaceutical company that acquires, develops, and commercializes novel oncology and hematology therapeutics, reported results for the 3 and 9 months ended 9/30/2006.
Latest news from Laboratory News from StratCenter.com:
- Abstract Evaluating QUADRAMET for Multiple Myeloma Presented erican Society of Hematology Annual Meeting
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- Stratagene Reports Q3 Results
- Viking Systems Appoints Dr Michael Manyak to Its Board
- Soliant Health To Exhibit at the American Speech-Language-Hearing Assoc Conference
- Sysmex America Awarded Contract to Service VA Med Cntrs in Midwest States
- Ronald D Luff, MD, Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease
- Launch of 'Egg Banking' Program Breaks New Ground as 1st Program of Its Kind in NC
- Global Care Quest Announces ICIS 5
- Portola Pharmaceuticals Presents Data Associated With Its Novel Anticoagulation Assay at American Heart Assoc Scientific Sessions